Invitae (NVTA) has released an update to notify the public and investors about a regulation fd disclosure.
On January 22, 2024, the Company announced through a press release the sale of its reproductive health assets to Natera. The detailed press release is provided for informational purposes only and is not legally binding under the Securities Exchange Act of 1934 nor shall it be used in any registration statement or document filed under the Securities Act of 1933 or the Securities Exchange Act, unless explicitly mentioned in such filings.
For further insights into NVTA stock, check out TipRanks’ Stock Analysis page.
